Katherine Berry, Katherine Hallock & Charlene Lam. (2023) Photoaging and Topical Rejuvenation. Clinics in Plastic Surgery 50:3, pages 381-390.
Crossref
Dayoung Ko, Rebecca F. Wang, David Ozog, Henry W. Lim & Tasneem F. Mohammad. (2023) Disorders of hyperpigmentation. Part II. Review of management and treatment options for hyperpigmentation. Journal of the American Academy of Dermatology 88:2, pages 291-320.
Crossref
Nimra Khan, Sofia Ahmed, Muhammad Ali Sheraz, Zubair Anwar & Iqbal Ahmad. 2023.
167
210
.
Woraphong Manuskiatti, Chadakan Yan, Ma. Christina Banate Gulfan, Thanya Techapichetvanich & Rungsima Wanitphakdeedecha. (2022) Combination of a 755‐nm picosecond laser and hydroquinone 2% cream versus hydroquinone 2% cream alone for the treatment of melasma: A randomized, split‐face, and controlled trial. Lasers in Surgery and Medicine 54:10, pages 1245-1250.
Crossref
Zuzanna Piętowska, Danuta Nowicka & Jacek C. Szepietowski. (2022) Understanding Melasma-How Can Pharmacology and Cosmetology Procedures and Prevention Help to Achieve Optimal Treatment Results? A Narrative Review. International Journal of Environmental Research and Public Health 19:19, pages 12084.
Crossref
Vikram K. Mahajan, Anant Patil, Leszek Blicharz, Martin Kassir, Nellie Konnikov, Michael H. Gold, Mitchel P. Goldman, Hassan Galadari & Mohamad Goldust. (2022) Medical therapies for melasma. Journal of Cosmetic Dermatology 21:9, pages 3707-3728.
Crossref
Katherine Berry, Katherine Hallock & Charlene Lam. (2022) Photoaging and Topical Rejuvenation. Facial Plastic Surgery Clinics of North America 30:3, pages 291-300.
Crossref
Mason Jarius Tangau, Yie Kie Chong & Keng Yoon Yeong. (2022) Advances in cosmeceutical nanotechnology for hyperpigmentation treatment. Journal of Nanoparticle Research 24:8.
Crossref
Kourtney Pony & Kiyanna Williams. (2022) A Multimodal Approach to Melasma. Advances in Cosmetic Surgery 5:1, pages 1-8.
Crossref
Kanika Kamal, Kerry Heitmiller & Mitalee Christman. (2022) Lasers, lights, and compounds for melasma in aesthetics. Clinics in Dermatology 40:3, pages 249-255.
Crossref
Chingshubam BikashRashmi SarkarVineet RelhanSarika Singh. (2022) Role of Platelet-Rich Plasma Therapy as an Adjuvant in Treatment of Melasma. Dermatologic Surgery 48:4, pages 429-434.
Crossref
J. Yoo. (2021) Differential diagnosis and management of hyperpigmentation. Clinical and Experimental Dermatology 47:2, pages 251-258.
Crossref
T. Searle, F. Al‐Niaimi & F. R. Ali. (2020) Hydroquinone: myths and reality. Clinical and Experimental Dermatology 46:4, pages 636-640.
Crossref
Jennifer Nguyen, Laura Remyn, In Young Chung, Anthony Honigman, Shima Gourani‐Tehrani, Ilycia Wutami, Celestine Wong, Eldho Paul & Michelle Rodrigues. (2020) Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double‐blinded trial. Australasian Journal of Dermatology 62:1.
Crossref
Shymaa Hatem, Nada M. El Hoffy, Reham S. Elezaby, Maha Nasr, Amany O. Kamel & Seham A. Elkheshen. (2020) Background and different treatment modalities for melasma: Conventional and nanotechnology-based approaches. Journal of Drug Delivery Science and Technology 60, pages 101984.
Crossref
Nahla Shihab, Joedo Prihartono, Andrea Tovar‐Garza, Triana Agustin, Lili Legiawati & Amit G Pandya. (2020) Randomised, controlled, double‐blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma. Australasian Journal of Dermatology 61:3, pages 237-242.
Crossref
Sameh S. M. Soliman, Rania Hamdy, Samia A. ElseginyTeclegiorgis GebremariamAlshaimaa M. Hamoda, Mohamed Madkour, Thenmozhi Venkatachalam, Mai N. Ershaid, Mohammad G. Mohammad, Georgios Chamilos & Ashraf S. Ibrahim. (2020)
Selective inhibition of
Rhizopus
eumelanin biosynthesis by novel natural product scaffold-based designs caused significant inhibition of fungal pathogenesis
. Biochemical Journal 477:13, pages 2489-2507.
Crossref
Jacqueline McKesey, Andrea Tovar-Garza & Amit G. Pandya. (2019) Melasma Treatment: An Evidence-Based Review. American Journal of Clinical Dermatology 21:2, pages 173-225.
Crossref
Lan Feng, Nannan Shi, Shasha Cai, Xue Qiao, Peng Chu, Hui Wang, Feida Long, Huaixin Yang, Yongliang Yang, Yipeng Wang & Haining Yu. (2018) De Novo Molecular Design of a Novel Octapeptide That Inhibits In Vivo Melanogenesis and Has Great Transdermal Ability. Journal of Medicinal Chemistry 61:15, pages 6846-6857.
Crossref
Harini R. BalaSenhong LeeCelestine WongAmit.G. PandyaMichelle Rodrigues. (2018) Oral Tranexamic Acid for the Treatment of Melasma: A Review. Dermatologic Surgery 44:6, pages 814-825.
Crossref
Mona Sadeghpour, Jeffrey S. Dover & Thomas E. Rohrer. (2018) Advances in the Treatment of Melasma. Advances in Cosmetic Surgery 1:1, pages 163-174.
Crossref
Priyadarshani Galappatthy & Deepani Rathnayake. 2018. Pigmentary Skin Disorders. Pigmentary Skin Disorders
261
280
.
Young-Jun Choi, Jae-Hui Nam, Jung Yup Kim, Joon Hong Min, Kui Young Park, Eun Jung Ko, Beom Joon Kim & Won-Serk Kim. (2017) Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial. Lasers in Surgery and Medicine 49:10, pages 899-907.
Crossref
Judy Cheng & Neelam A. Vashi. 2017. Dermatoanthropology of Ethnic Skin and Hair. Dermatoanthropology of Ethnic Skin and Hair
417
436
.
Sandra Maria Barbosa Durães, Rosa Rabello Fonseca & Maria Claudia Almeida Issa. 2017. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology
67
99
.
Eubee Koo, Alexandra B. Kimball & Molly Wanner. 2016. Rook's Textbook of Dermatology, Ninth Edition. Rook's Textbook of Dermatology, Ninth Edition
1
16
.
Jasmine S. McNair & Porcia B. Love. 2016. Clinical Cases in Skin of Color. Clinical Cases in Skin of Color
135
146
.
Sandra Maria Barbosa Durães, Rosa Rabello Fonseca & Maria Claudia Almeida Issa. 2016. Daily Routine in Cosmetic Dermatology. Daily Routine in Cosmetic Dermatology
1
34
.
Sini K. Radhakrishnan, Ronald G. Shimmon, Costa Conn & Anthony T. Baker. (2016) Evaluation of Novel Chalcone Oximes as Inhibitors of Tyrosinase and Melanin Formation in B16 Cells. Archiv der Pharmazie 349:1, pages 20-29.
Crossref
Sini Radhakrishnan, Ronald Shimmon, Costa Conn & Anthony Baker. (2015) Development of hydroxylated naphthylchalcones as polyphenol oxidase inhibitors: Synthesis, biochemistry and molecular docking studies. Bioorganic Chemistry 63, pages 116-122.
Crossref
Sini Radhakrishnan, Ronald Shimmon, Costa Conn & Anthony Baker. (2015) Integrated kinetic studies and computational analysis on naphthyl chalcones as mushroom tyrosinase inhibitors. Bioorganic & Medicinal Chemistry Letters 25:19, pages 4085-4091.
Crossref
Michelle Rodrigues & Amit G Pandya. (2015) Melasma: clinical diagnosis and management options. Australasian Journal of Dermatology 56:3, pages 151-163.
Crossref
Zeinab A Ibrahim, Shereen F Gheida, Gamal M El Maghraby & Zeinab E Farag. (2015) Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. Journal of Cosmetic Dermatology 14:2, pages 113-123.
Crossref
Maria Teresa Truchuelo, Natalia Jiménez & Pedro Jaén. (2014) Assessment of the efficacy and tolerance of a new combination of retinoids and depigmenting agents in the treatment of melasma. Journal of Cosmetic Dermatology 13:4, pages 261-268.
Crossref
Jung Won Shin & Kyoung Chan Park. (2014) Current clinical use of depigmenting agents. Dermatologica Sinica 32:4, pages 205-210.
Crossref
Asad Salim, Ratna Rajaratnam & Eva Soos Domanne. 2014. Evidence‐Based Dermatology. Evidence‐Based Dermatology
470
485
.
Gurpreet Singh Jutley, Ratna Rajaratnam, James Halpern, Asad Salim & Charis Emmett. (2014) Systematic review of randomized controlled trials on interventions for melasma: An abridged Cochrane review. Journal of the American Academy of Dermatology 70:2, pages 369-373.
Crossref
Ching-Yi Lien, Ching-Yu Chen, Shih-Ting Lai & Chin-Feng Chan. (2014)
Kinetics of Mushroom Tyrosinase and Melanogenesis Inhibition by
N
-Acetyl-pentapeptides
. The Scientific World Journal 2014, pages 1-9.
Crossref
N.A. Vashi & R.V. Kundu. (2013) Facial hyperpigmentation: causes and treatment. British Journal of Dermatology 169, pages 41-56.
Crossref
Shelly Rivas & Amit G. Pandya. (2013) Treatment of Melasma with Topical Agents, Peels and Lasers: An Evidence-Based Review. American Journal of Clinical Dermatology 14:5, pages 359-376.
Crossref
Tsz Wah Tse & Edith Hui. (2013) Tranexamic acid: an important adjuvant in the treatment of melasma. Journal of Cosmetic Dermatology 12:1, pages 57-66.
Crossref
So Yeon Paek & Amit G. Pandya. 2013. Skin of Color. Skin of Color
139
160
.
Anan Abu Ubeid, Sylvia Do, Chris Nye & Basil M. Hantash. (2012) Potent low toxicity inhibition of human melanogenesis by novel indole-containing octapeptides. Biochimica et Biophysica Acta (BBA) - General Subjects 1820:10, pages 1481-1489.
Crossref
Vaneeta M. Sheth & Amit G. Pandya. (2011) Melasma: A comprehensive update. Journal of the American Academy of Dermatology 65:4, pages 699-714.
Crossref
Ilaria Ghersetich, Andrea Bassi, Silvia Betti, Piero Campolmi & Torello Lotti. (2011) Treatment options for melasma: an update. Prime 1:3, pages 16-27.
Crossref
Alain Taïeb, Muriel Cario‐André, Stefania Briganti & Mauro Picardo. 2011. Melanins and Melanosomes. Melanins and Melanosomes
117
165
.
Evangeline B. Handog & Maria Juliet E. Macarayo. 2012. Color Atlas of Chemical Peels. Color Atlas of Chemical Peels
123
139
.
Sreedevi Kodali, Ian L. Guevara, Christina R. Carrigan, Seema Daulat, Gabriela Blanco, Andreas Boker, Linda S. Hynan & Amit G. Pandya. (2010) A prospective, randomized, split-face, controlled trial of salicylic acid peels in the treatment of melasma in Latin American women. Journal of the American Academy of Dermatology 63:6, pages 1030-1035.
Crossref
Ratna Rajaratnam, James Halpern, Asad Salim & Charis Emmett. (2010) Interventions for melasma. Cochrane Database of Systematic Reviews.
Crossref
Anan Abu Ubeid, Longmei Zhao, Ying Wang & Basil M. Hantash. (2009) Short-Sequence Oligopeptides with Inhibitory Activity against Mushroom and Human Tyrosinase. Journal of Investigative Dermatology 129:9, pages 2242-2249.
Crossref
T Cestari, I Arellano, D Hexsel & JP Ortonne. (2009) Melasma in Latin America: options for therapy and treatment algorithm. Journal of the European Academy of Dermatology and Venereology 23:7, pages 760-772.
Crossref
Ilgen ERTAM, Basak MUTLU, Idil UNAL, Sibel ALPER, Bijen KIVÇAK & Ozgen OZER. (2008) Efficiency of ellagic acid and arbutin in melasma: A randomized, prospective, open-label study. The Journal of Dermatology 35:9, pages 570-574.
Crossref
L. W. Draijer, H. Folmer & M. M. Verduijn. (2008) NHG-Farmacotherapeutische richtlijn Melasma/chloasma. Huisarts en Wetenschap 51:9, pages 447-450.
Crossref
Francesca Prignano, Jean-Paul Ortonne, Gionata Buggiani & Torello Lotti. (2007) Therapeutical Approaches in Melasma. Dermatologic Clinics 25:3, pages 337-342.
Crossref
A. Khemis, A. Kaiafa, C. Queille-Roussel, L. Duteil & J.P. Ortonne. (2007) Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial. British Journal of Dermatology 156:5, pages 997-1004.
Crossref
Francisco Solano, Stefania Briganti, Mauro Picardo & Ghanem Ghanem. (2006) Hypopigmenting agents: an updated review on biological, chemical and clinical aspects. Pigment Cell Research 19:6, pages 550-571.
Crossref
D. Hexsel, I. Arellano & M. Rendon. (2006) Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. British Journal of Dermatology 156:s1, pages 7-12.
Crossref
Marta Rendon, Mark Berneburg, Ivonne Arellano & Mauro Picardo. (2006) Treatment of melasma. Journal of the American Academy of Dermatology 54:5, pages S272-S281.
Crossref